{"id":"https://openalex.org/W1869200070","doi":"https://doi.org/10.1002/14651858.cd010816.pub2","title":"Bortezomib for the treatment of multiple myeloma","display_name":"Bortezomib for the treatment of multiple myeloma","publication_year":2016,"publication_date":"2016-04-20","ids":{"openalex":"https://openalex.org/W1869200070","doi":"https://doi.org/10.1002/14651858.cd010816.pub2","mag":"1869200070","pmid":"https://pubmed.ncbi.nlm.nih.gov/27096326","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10387344"},"language":"en","primary_location":{"id":"doi:10.1002/14651858.cd010816.pub2","doi":"https://doi.org/10.1002/14651858.cd010816.pub2","is_oa":true,"landing_page_url":"https://doi.org/10.1002/14651858.cd010816.pub2","pdf_url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010816.pub2/pdf/full","source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010816.pub2/pdf/full","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Kathleen Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I4210103332","display_name":"Cancer Trials Ireland","ror":"https://ror.org/01dpkyq75","country_code":"IE","type":"facility","lineage":["https://openalex.org/I4210103332"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Kathleen Scott","raw_affiliation_strings":["All Ireland Cooperative Oncology Research Group (ICORG); 60 Fitzwilliam Square Dublin Ireland","Trinity College Dublin; School of Nursing & Midwifery; 24 D'Olier St Dublin Ireland","School of Nursing and Midwifery, Trinity College Dublin, 24 D'Olier St, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All Ireland Cooperative Oncology Research Group (ICORG); 60 Fitzwilliam Square Dublin Ireland","institution_ids":["https://openalex.org/I4210103332"]},{"raw_affiliation_string":"Trinity College Dublin; School of Nursing & Midwifery; 24 D'Olier St Dublin Ireland","institution_ids":["https://openalex.org/I205274468"]},{"raw_affiliation_string":"School of Nursing and Midwifery, Trinity College Dublin, 24 D'Olier St, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103189215","display_name":"Patrick John Hayden","orcid":"https://orcid.org/0000-0003-1374-4503","observed_orcids":["https://orcid.org/0000-0003-1374-4503","https://orcid.org/0000-0002-5396-9267"]},"institutions":[{"id":"https://openalex.org/I4210154619","display_name":"St. James's Hospital","ror":"https://ror.org/04c6bry31","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210154619"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Patrick J Hayden","raw_affiliation_strings":["St James\u00b4s Hospital; Dublin Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St James\u00b4s Hospital; Dublin Ireland","institution_ids":["https://openalex.org/I4210154619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080129889","display_name":"Andrea Will","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]},{"id":"https://openalex.org/I4210161245","display_name":"Cochrane Canada","ror":"https://ror.org/05cf80b72","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210161245","https://openalex.org/I72054575"]}],"countries":["CA","DE"],"is_corresponding":false,"raw_author_name":"Andrea Will","raw_affiliation_strings":["University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937","institution_ids":["https://openalex.org/I4210153755","https://openalex.org/I4210161245"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018693666","display_name":"Keith Wheatley","orcid":"https://orcid.org/0000-0003-0792-580X","observed_orcids":["https://orcid.org/0000-0003-0792-580X"]},"institutions":[{"id":"https://openalex.org/I4210135017","display_name":"Cancer Research UK Clinical Trials Unit","ror":"https://ror.org/03qxptw71","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210135017","https://openalex.org/I79619799"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith Wheatley","raw_affiliation_strings":["University of Birmingham; Cancer Research Clinical Trials Unit, School of Cancer Sciences; Edgbaston Birmingham UK B15 2TT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham; Cancer Research Clinical Trials Unit, School of Cancer Sciences; Edgbaston Birmingham UK B15 2TT","institution_ids":["https://openalex.org/I4210135017","https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046819370","display_name":"Imelda Coyne","orcid":"https://orcid.org/0000-0003-0977-8428","observed_orcids":["https://orcid.org/0000-0003-0977-8428"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Imelda Coyne","raw_affiliation_strings":["Trinity College Dublin; School of Nursing & Midwifery; 24 D'Olier St Dublin Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trinity College Dublin; School of Nursing & Midwifery; 24 D'Olier St Dublin Ireland","institution_ids":["https://openalex.org/I205274468"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5100,"currency":"USD","value_usd":5100},"apc_paid":null,"fwci":1.751,"has_fulltext":true,"cited_by_count":162,"citation_normalized_percentile":{"value":0.88372093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"2016","issue":"4","first_page":"CD010816","last_page":"CD010816"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9200000166893005},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.800000011920929},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9359999895095825},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8069999814033508},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.9819999933242798},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.9070000052452087},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6209999918937683},{"id":"https://openalex.org/keywords/treatment-schedule-comparison","display_name":"treatment schedule comparison","score":0.6570000052452087},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5659999847412109},{"id":"https://openalex.org/keywords/risk-of-bias","display_name":"risk of bias","score":0.5289999842643738},{"id":"https://openalex.org/keywords/risk-of-overstatement","display_name":"risk of overstatement","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.9417306184768677},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8332874774932861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48571476340293884},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4476355016231537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38390135765075684}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1002/14651858.cd010816.pub2","doi":"https://doi.org/10.1002/14651858.cd010816.pub2","is_oa":true,"landing_page_url":"https://doi.org/10.1002/14651858.cd010816.pub2","pdf_url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010816.pub2/pdf/full","source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10387344","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10387344","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10387344/pdf/CD010816.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database Syst Rev","raw_type":"Text"},{"id":"pmid:27096326","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27096326","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cochrane database of systematic reviews","raw_type":"Journal Article"},{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:28992","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/28992/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:article"},{"id":"pmh:oai:pure.atira.dk:openaire/98a32362-a64a-4512-96e9-c27d958c52b4","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/98a32362-a64a-4512-96e9-c27d958c52b4","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scott, K, Hayden, P J, Will, A, Wheatley, K & Coyne, I 2016, 'Bortezomib for the treatment of multiple myeloma', Cochrane Database of Systematic Reviews, vol. 2016, no. 4, CD010816. https://doi.org/10.1002/14651858.CD010816.pub2","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:tara.tcd.ie:2262/67955","doi":null,"is_oa":false,"landing_page_url":"http://people.tcd.ie/haydenp","pdf_url":null,"source":{"id":"https://openalex.org/S4306400387","display_name":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I205274468","host_organization_name":"Trinity College Dublin","host_organization_lineage":["https://openalex.org/I205274468"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/14651858.cd010816.pub2","doi":"https://doi.org/10.1002/14651858.cd010816.pub2","is_oa":true,"landing_page_url":"https://doi.org/10.1002/14651858.cd010816.pub2","pdf_url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010816.pub2/pdf/full","source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[{"id":"https://openalex.org/G9000370754","display_name":null,"funder_award_id":"ICORG-2016-1","funder_id":"https://openalex.org/F4320312041","funder_display_name":"Health Research Board"}],"funders":[{"id":"https://openalex.org/F4320312041","display_name":"Health Research Board","ror":"https://ror.org/003hb2249"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1869200070.pdf","grobid_xml":"https://content.openalex.org/works/W1869200070.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W246286872","https://openalex.org/W1496735223","https://openalex.org/W1554040650","https://openalex.org/W1586223754","https://openalex.org/W1596902544","https://openalex.org/W1724355557","https://openalex.org/W1968544465","https://openalex.org/W1969903464","https://openalex.org/W1981989535","https://openalex.org/W1990152834","https://openalex.org/W1992003712","https://openalex.org/W1993959807","https://openalex.org/W2008480201","https://openalex.org/W2009426416","https://openalex.org/W2012345849","https://openalex.org/W2013370486","https://openalex.org/W2023661149","https://openalex.org/W2028195916","https://openalex.org/W2037203692","https://openalex.org/W2038378122","https://openalex.org/W2039496823","https://openalex.org/W2039944287","https://openalex.org/W2055338149","https://openalex.org/W2071434932","https://openalex.org/W2075642745","https://openalex.org/W2087887347","https://openalex.org/W2088095316","https://openalex.org/W2088765731","https://openalex.org/W2089311432","https://openalex.org/W2095255742","https://openalex.org/W2096207943","https://openalex.org/W2099077086","https://openalex.org/W2099395323","https://openalex.org/W2103289287","https://openalex.org/W2107154392","https://openalex.org/W2108235071","https://openalex.org/W2111650326","https://openalex.org/W2120780398","https://openalex.org/W2124560610","https://openalex.org/W2127192057","https://openalex.org/W2127760782","https://openalex.org/W2134902298","https://openalex.org/W2142368474","https://openalex.org/W2143621111","https://openalex.org/W2150878522","https://openalex.org/W2151595053","https://openalex.org/W2156098321","https://openalex.org/W2158106888","https://openalex.org/W2159195400","https://openalex.org/W2169183166","https://openalex.org/W2327230065","https://openalex.org/W2410469448","https://openalex.org/W2473482436","https://openalex.org/W2547069390","https://openalex.org/W2556510606","https://openalex.org/W2560868376","https://openalex.org/W2584992717","https://openalex.org/W2744601260","https://openalex.org/W2901224145","https://openalex.org/W3195431600","https://openalex.org/W4206709508","https://openalex.org/W4211135634","https://openalex.org/W4252175385","https://openalex.org/W4294215472","https://openalex.org/W4362504902","https://openalex.org/W6698804469","https://openalex.org/W6700515692","https://openalex.org/W6720510421"],"related_works":["https://openalex.org/W2790460557","https://openalex.org/W4283703258","https://openalex.org/W1977303037","https://openalex.org/W2102191670","https://openalex.org/W2516868511","https://openalex.org/W2913522057","https://openalex.org/W7120881181","https://openalex.org/W2779840252","https://openalex.org/W2038378122","https://openalex.org/W2123602239"],"abstract_inverted_index":{"BACKGROUND:":[0],"Multiple":[1],"myeloma":[2,575],"is":[3,25,280,329,480,517,638],"a":[4,49,234],"malignancy":[5],"of":[6,13,17,58,72,91,161,181,236,276,316,368,393,426,433,462,475,486,492,510,524,582,602,615,634,653],"plasma":[7],"cells":[8],"accounting":[9],"for":[10,109,192,200,351,424,483,548,554,564],"approximately":[11],"1%":[12],"cancers":[14],"and":[15,52,78,94,105,154,159,165,178,188,194,196,204,246,257,267,299,395,398,415,420,470,531,561,585,612],"12%":[16],"haematological":[18],"malignancies.":[19],"The":[20,508],"first-in-class":[21],"proteasome":[22,636],"inhibitor,":[23],"bortezomib,":[24],"commonly":[26],"used":[27],"to":[28,54,151,210,272,297,311,346,363,382,412,418,520,589,629,640],"treat":[29],"newly":[30],"diagnosed":[31],"as":[32,34,38,100,102,440],"well":[33,101],"relapsed/refractory":[35],"myeloma,":[36],"either":[37,513],"single":[39],"agent":[40],"or":[41,149,380,504,627],"combined":[42],"with":[43,129,142,321,373,457,472,497,607,620],"other":[44,152,383,506,630],"therapies.":[45],"OBJECTIVES:":[46],"We":[47,84,116,183,206,216,224,232,446],"conducted":[48],"systematic":[50],"review":[51,172],"meta-analysis":[53,408,572],"assess":[55,273],"the":[56,87,130,251,322,407,427,431,473,521,525,532,608],"effects":[57],"bortezomib":[59,125,128,138,141,156,284,317,320,333,369,372,458,493,496,555,578,603,606,616,619],"on":[60],"overall":[61],"survival":[62,65],"(OS),":[63],"progression-free":[64],"(PFS),":[66],"response":[67,201,586],"rate":[68,587],"(RR),":[69],"health-related":[70],"quality":[71,474,523],"life":[73],"(HRQoL),":[74],"adverse":[75],"events":[76],"(AEs)":[77],"treatment-related":[79],"death":[80],"(TRD).":[81],"SEARCH":[82],"METHODS:":[83],"searched":[85],"MEDLINE,":[86],"Cochrane":[88],"Central":[89],"Register":[90],"Controlled":[92],"Trials":[93],"EMBASE":[95],"(till":[96],"27":[97],"January":[98],"2016)":[99],"conference":[103],"proceedings":[104],"clinical":[106],"trial":[107,208],"registries":[108],"randomised":[110,118,256],"controlled":[111,119],"trials":[112,120,249,254,261,315,367,385,405,491,528,601,614],"(RCTs).":[113],"SELECTION":[114],"CRITERIA:":[115],"included":[117,247,437],"(RCTs)":[121],"that":[122,283,332,409,574],"compared":[123,150,381,588,628],"i)":[124],"versus":[126,139,318,370,494,505,604,617],"no":[127,140,319,371,495,605,618],"same":[131,323,609],"background":[132,144,324,375,499,610,622],"therapy":[133,145,325,376,500,549,611,623],"in":[134,146,250,264,278,326,377,406,430,453,501,512,544,558,580,600,613,624],"each":[135,147,327,378,502,625],"arm;":[136],"ii)":[137],"different":[143,162,374,390,498,621],"arm":[148,379,503,626],"agent(s)":[153],"iii)":[155],"dose":[157],"comparisons":[158,160],"treatment":[163,396],"administrations":[164,394],"schedules.":[166],"DATA":[167],"COLLECTION":[168],"AND":[169],"ANALYSIS:":[170],"Two":[171,260],"authors":[173,209],"independently":[174],"extracted":[175,184,225],"outcomes":[176,560],"data":[177,423,439,442,533],"assessed":[179],"risk":[180,275,461,485,509],"bias.":[182],"hazard":[185],"ratios":[186,198],"(HR)":[187],"their":[189],"confidence":[190],"intervals":[191],"OS":[193,286,335,565],"PFS":[195,300,352,422,441,584],"odds":[197],"(OR)":[199],"rates,":[202],"AEs":[203],"TRD.":[205],"contacted":[207],"provide":[211],"summary":[212],"statistics":[213,219],"if":[214],"missing.":[215],"estimated":[217],"Logrank":[218],"which":[220],"were":[221,255,262,270,399,416,443],"not":[222,444,449,535,593],"available.":[223,229,445],"HRQoL":[226,530,654],"data,":[227],"where":[228],"MAIN":[230],"RESULTS:":[231],"screened":[233],"total":[235],"3667":[237],"records,":[238],"identifying":[239],"16":[240],"relevant":[241],"RCTs":[242],"involving":[243],"5626":[244],"patients":[245,576],"12":[248],"meta-analyses.":[252],"All":[253],"open-label":[258],"studies.":[259],"published":[263],"abstract":[265],"form":[266],"therefore":[268,447],"we":[269,436],"unable":[271],"potential":[274],"bias":[277],"full.There":[279],"moderate-quality":[281],"evidence":[282,331,350,476,482],"prolongs":[285,334],"(four":[287,353],"studies,":[288,302,337,354,428],"1586":[289],"patients;":[290,304,339,356],"Peto":[291,305,340,357],"OR":[292,306,341,358],"0.77,":[293],"95%":[294,308,343,360],"CI":[295,309,344,361],"0.65":[296],"0.92)":[298],"(five":[301,336],"1855":[303],"0.65,":[307],"0.57":[310],"0.74)":[312],"from":[313,365,489],"analysing":[314,366,490],"arm.There":[328],"high-quality":[330,481],"2532":[338],"0.76,":[342],"0.67":[345],"0.88)":[347],"but":[348],"low-quality":[349],"2489":[355],"0.67,":[359],"0.61":[362],"0.75)":[364],"agent(s).Four":[384],"(N":[386],"=":[387],"716)":[388],"examined":[389],"doses,":[391],"methods":[392],"schedules":[397],"reviewed":[400],"qualitatively":[401],"only.We":[402],"identified":[403],"four":[404,527],"measured":[410],"time":[411],"progression":[413],"(TTP)":[414],"able":[417],"extract":[419],"analyse":[421,450],"three":[425],"while":[429,650],"case":[432],"one":[434],"study,":[435],"TTP":[438,451],"did":[448,592],"separately":[452],"this":[454],"review.Patients":[455],"treated":[456],"have":[459],"increased":[460,484],"thrombocytopenia,":[463],"neutropenia,":[464],"gastro-intestinal":[465],"toxicities,":[466],"peripheral":[467],"neuropathy,":[468],"infection":[469],"fatigue":[471],"highly":[477],"variable.":[478],"There":[479],"cardiac":[487],"disorders":[488],"agents.":[507],"TRD":[511],"comparison":[514],"group":[515],"analysed":[516,529],"uncertain":[518],"due":[519],"low":[522],"evidence.Only":[526],"could":[534],"be":[536],"meta-analysed.Subgroup":[537],"analyses":[538],"by":[539],"disease":[540],"setting":[541],"revealed":[542],"improvements":[543],"all":[545,559],"outcomes,":[546],"whereas":[547],"setting,":[550],"an":[551,646],"improved":[552,647],"benefit":[553,597],"was":[556,598],"observed":[557,599],"subgroups":[562],"except":[563],"following":[566],"consolidation":[567],"therapy.":[568],"AUTHORS'":[569],"CONCLUSIONS:":[570],"This":[571,596],"found":[573],"receiving":[577],"benefited":[579],"terms":[581],"OS,":[583],"those":[590],"who":[591],"receive":[594],"bortezomib.":[595],"agent(s).":[631],"Further":[632],"evaluation":[633],"newer":[635],"inhibitors":[637],"required":[639],"ascertain":[641],"whether":[642],"these":[643],"agents":[644],"offer":[645],"risk-benefit":[648],"profile,":[649],"more":[651],"studies":[652],"are":[655],"also":[656],"required.":[657]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":29},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}